Abstract
Duloxetine (Cymbalta) is a serotonin and norepinephrine reuptake inhibitor in the same class as venlafaxine (Effexor). It is approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of major depressive disorder and of diabetic peripheral neuropathic pain. In Europe it is marketed for the treatment of stress urinary incontinence; it is not approved for that indication in the United States.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1099-1102 |
| Number of pages | 4 |
| Journal | American family physician |
| Volume | 72 |
| Issue number | 6 |
| State | Published - Sep 15 2005 |
